Real-world prevalence of prurigo nodularis and burden of associated diseases.

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Journal of Investigative Dermatology

• Publication date

  2020-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jid.2019.07.697PMID 31421126
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association between prurigo nodularis and malignancy in middle-aged adults.

  2019cited by this paper
• Psoriasis and the metabolic syndrome.

  2018cited by this paper
• Ethnic differences and comorbidities of 909 prurigo nodularis patients

  2018cited by this paper
• Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder.

  2017cited by this paper
• Anxiety, depression and suicide in patients with prurigo nodularis

  2017cited by this paper
• Real‐world burden of comorbidities in US patients with psoriasis

  2017cited by this paper
• Chronic pruritus in HIV-positive patients in the southeastern United States: its prevalence and effect on quality of life.

  2014cited by this paper
• Prurigo as a symptom of atopic and non‐atopic diseases: aetiological survey in a consecutive cohort of 108 patients

  2013cited by this paper
• Keratoacanthomas arising in association with prurigo nodules in pruritic, actinically damaged skin.

  2013cited by this paper
• Metabolic Syndrome in Patients with Psoriatic Disease

  2012cited by this paper
• Predictive values of prurigo nodularis and herpes zoster for HIV infection and immunosuppression requiring HAART in French Guiana.

  2011cited by this paper
• Cem: Coarsened Exact Matching in Stata

  2009cited by this paper
• Nodular prurigo: metabolic diseases are a common association

  2007cited by this paper
• Acute phototoxicity with urticarial features during topical 5‐aminolaevulinic acid photodynamic therapy

  2007cited by this paper
• Prurigo nodularis consists of two distinct forms: early-onset atopic and late-onset non-atopic.

  1995cited by this paper

• Prurigo Nodularis Increases Risk of Non-alcoholic Fatty Liver Disease and Liver Cirrhosis: A Global-federated Retrospective Cohort Study

  2026cites this paper
• Addressing Unmet Needs in Prurigo Nodularis: Expert Canadian Dermatology Perspectives

  2026cites this paper
• Itching for relief: A review of the psychological impact of prurigo nodularis

  2026cites this paper
• IgE-defined endotypes reveal distinct clinical profiles of prurigo nodularis compared with atopic dermatitis: a multicenter study in China

  2026cites this paper
• Clinical perspectives on prurigo nodularis: diagnostic challenges and novel treatment options.

  2025cites this paper
• New-onset Autoimmune Diseases in Patients with Prurigo Nodularis: A Global-federated Retrospective Cohort Study

  2025cites this paper
• A Retrospective Analysis of Itch Intensity and Comorbidities in Lichen Simplex Chronicus

  2025cites this paper
• Major Depressive Disorder, Bipolar Disorder and Schizophrenia in Patients with Prurigo Nodularis: a Multicenter Retrospective Cohort Study derived from TriNetX research network.

  2025cites this paper
• Treatment Patterns, Healthcare Utilization, and Related Costs for Prurigo Nodularis in Sweden

  2025cites this paper
• Clinical, Histopathological, and Direct Immunofluorescence Characteristics of Prurigo‐Nodularis‐Like Lesions and Pruritus: A Retrospective Study of Patients Admitted to a Tertiary Dermatology Hospital

  2025cites this paper
• Prurigo nodularis: disease burden, clinical features and approach to management.

  2025cites this paper
• Th2 mRNA gene expression analysis separates Prurigo nodularis into two immune signature groups

  2025cites this paper
• Comorbidities and Healthcare Utilization in 4197 Patients With Prurigo Nodularis in Israel: A Cross-Sectional Population-Based Analysis.

  2025cites this paper
• Quantitative Evaluation of Nemolizumab Pharmacokinetics and Efficacy in Prurigo Nodularis: A Population Pharmacokinetics and Model-Based Meta-analysis Approach

  2025cites this paper
• Prurigo nodularis and associated dermatological conditions in Finland from 1995 to 2022.

  2025cites this paper
• Comorbidities in Prurigo Nodularis.

  2025cites this paper
• Effect of tralokinumab on moderate-to-severe atopic dermatitis in patients with atopic comorbidities.

  2025cites this paper
• Clinical Characteristics, Diagnostic Approaches, Therapeutic Management, and Associated Comorbidities of Prurigo Nodularis (Chronic Nodular Prurigo): An Observational Study in Clinical Practice in Spain

  2025cites this paper
• Prurigo Nodularis PaTient-Reported BurdEn of SicKness (PN TREK): A Cross-Sectional Survey of Patient-Reported Burden of Disease in Patients with PN from the US

  2025influential citation
• Chronic prurigo: current insights and future directions

  2025cites this paper
• Content Validity and Psychometric Validation of an Adapted Version of the Subject Sleep Diary in Prurigo Nodularis

  2025cites this paper
• Epidemiology and Severity of Prurigo Nodularis in Europe: A Literature Review with an Application to Italian Data

  2025cites this paper
• Taiwanese Dermatological Association consensus for the diagnosis and management of prurigo nodularis

  2025cites this paper
• Prurigo Nodularis and the Microbiome.

  2025cites this paper
• Efficacy and Safety of Tofacitinib in Patients With Refractory Prurigo Nodularis: A 16‐Week, Single‐Center, Prospective, Observational Pilot Study

  2025cites this paper
• Type 2 Inflammation and Its Role in Dermatologic Diseases

  2025cites this paper
• Prurigo nodularis phenotype in the bullous dermatoses spectrum.

  2025cites this paper
• Long-term (68 weeks) administration of nemolizumab and topical corticosteroids for prurigo nodularis in patients aged ≥13 years: efficacy and safety data from a phase II/III study.

  2025cites this paper
• Prurigo Nodularis and Acquired Perforating Dermatosis in Chronic Kidney Disease: Are They the Same Entity?

  2025cites this paper
• Diagnosis and management of prurigo nodularis in skin of color patients.

  2025cites this paper
• Cross-sectional analysis of mental health comorbidities in patients with prurigo nodularis.

  2025cites this paper
• Current Status of Prurigo Nodularis in Japan: A Retrospective Study Using a Health Insurance Claims Database

  2025influential citation
• Healthcare Resource Utilization and Economic Burden of Prurigo Nodularis in the United States

  2025influential citation
• Worldwide prevalence of prurigo nodularis: A systematic review and meta‐analysis

  2025cites this paper
• Risk of malignancy in patients with prurigo nodularis: A systematic review and meta‐analysis

  2025cites this paper
• Epidemiology of prurigo nodularis: An analysis of global trends from 1998–2023

  2025cites this paper
• Vixarelimab in Patients With Prurigo Nodularis

  2025cites this paper
• Incidence and Prevalence of Prurigo Nodularis from 1995 to 2022: A Nationwide Registry Study from Finland

  2025cites this paper
• Comparative safety profiles of dupilumab and nemolizumab in prurigo nodularis: an indirect META-analysis to inform clinical decision-making

  2025cites this paper
• Efficacy and Safety of Dupilumab in Adults with Prurigo Nodularis with or Without Atopic Comorbidities: A Subgroup Analysis from Two Randomized Phase III Clinical Trials

  2025cites this paper
• Modulatory effects of bioactive natural compounds on pruritic pathways: mechanistic basis and therapeutic prospects

  2025cites this paper
• A critical evaluation of nemolizumab for prurigo nodularis

  2024cites this paper
• Single-cell RNA sequencing reveals dysregulated POSTN+WNT5A+ fibroblast subclusters in prurigo nodularis.

  2024cites this paper
• New insight into prurigo nodularis: Proadrenomedullin N‐terminal 20 peptide mediates mouse mast cell activation via Mrgprb2

  2024cites this paper
• Prurigo: review of its pathogenesis, diagnosis, and treatment

  2024cites this paper
• Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: Results from a randomised, double-blind, placebo-controlled, phase II/III clinical study in patients aged ≥13 years.

  2024cites this paper
• Comorbidities of prurigo nodularis in Chinese patients: A multicenter retrospective study

  2024cites this paper
• Systemic Biologic Management of Atopic Dermatitis.

  2024cites this paper
• Break the Itch-Scratch Cycle to Treat Prurigo Nodularis.

  2024cites this paper
• Prurigo Nodularis: Pathogenesis and the Horizon of Potential Therapeutics

  2024influential citation
• The Significant Role of Atopic Skin Diathesis in Prurigo Nodularis

  2024cites this paper
• Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.

  2024cites this paper
• Incidence and prevalence of prurigo nodularis and associated comorbidities in Denmark from 1995 to 2021.

  2024cites this paper
• An Update on Prurigo Nodularis in Skin of Color.

  2024cites this paper
• Association between atopic dermatitis and prurigo nodularis: a systematic review and meta‐analysis

  2024cites this paper
• Healthcare resource utilization and related cost among hospitalized patients with prurigo nodularis: a retrospective cohort study using Italian health claims data.

  2024cites this paper
• Prurigo Nodularis Mechanisms and Current Management Options.

  2024influential citation
• Current clinical practice of prurigo nodularis in Japan: A cross‐sectional web‐survey among dermatologists

  2024cites this paper
• A randomized, double‐blinded, vehicle‐controlled clinical trial of topical cryosim‐1, a synthetic TRPM8 agonist, in prurigo nodularis

  2024cites this paper
• Pathophysiology of Prurigo Nodularis: Neuroimmune Dysregulation and the Role of Type 2 Inflammation.

  2024cites this paper
• Abrocitinib Monotherapy for Refractory Prurigo Nodularis: Report of Two Successful Cases

  2024cites this paper
• A Fleshy Mystery: Prurigo Nodularis

  2024cites this paper
• Therapie der chronischen Prurigo: Update und Perspektive

  2024cites this paper
• Prevalence, Incidence and Treatment Patterns of Prurigo Nodularis in England: A Retrospective Database Analysis.

  2024cites this paper
• Increased cardiovascular risks and mortality in prurigo nodularis: a global cohort study

  2024cites this paper
• Prurigo: revisão de sua patogênese, diagnóstico e tratamento

  2024cites this paper
• Patient Perspectives on Living With Severe Prurigo Nodularis

  2023cites this paper
• Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study

  2023cites this paper
• Dupilumab for the treatment of prurigo nodularis: A systematic review

  2023cites this paper
• Single-cell RNA sequencing reveals dysregulated fibroblast subclusters in prurigo nodularis

  2023cites this paper
• The blood proteomic signature of prurigo nodularis (PN) reveals distinct inflammatory and neuropathic endotypes: a cluster analysis.

  2023cites this paper
• Effectiveness of 0.1% mometasone furoate under hydrocolloid dressing versus 0.1% mometasone furoate in patients with lichen simplex chronicus

  2023influential citation
• Skin Microbiome in Prurigo Nodularis

  2023cites this paper
• Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials

  2023cites this paper
• A polygenic risk score for predicting racial and genetic susceptibility to prurigo nodularis.

  2023cites this paper
• The Sleep Disturbance Numerical Rating Scale: Content Validity, Psychometric Validation, and Meaningful Within-Patient Change in Prurigo Nodularis

  2023cites this paper
• Prevalence and comorbidity burden of prurigo nodularis in United States adults enrolled in the All of Us research program.

  2023cites this paper
• Risk of incident sleep disorders in patients with prurigo nodularis: A population-level analysis using The Health Improvement Network

  2023cites this paper
• Type 2 chronic inflammatory diseases: targets, therapies and unmet needs

  2023cites this paper
• Clinical utility of peripheral blood laboratory testing in the diagnostic workup of prurigo nodularis: A multicenter cohort study

  2023cites this paper
• Validation of the Peak Pruritus Numerical Rating Scale as a Patient-Reported Outcome Measure in Prurigo Nodularis

  2023cites this paper
• Zinc Oxide Patches Are a Highly Effective Treatment for Chronic Prurigo: A Randomized Split-Body Study

  2023cites this paper
• Incident Comorbidity, Resource Use, and All-Cause Mortality Associated with Prurigo Nodularis: A United Kingdom Retrospective Database Analysis

  2023cites this paper
• Chronische Prurigo

  2023cites this paper
• Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments

  2023influential citation
• Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi‐Criteria Decision Analysis

  2023cites this paper
• Comorbidities of Chronic Prurigo: A Systematic Review and Meta-Analysis

  2023cites this paper
• Disease burden and treatment satisfaction in patients with prurigo nodularis in Japan

  2023cites this paper
• Eficácia do dupilumabe para prurigo crônico em paciente idoso com dermatite atópica

  2023cites this paper
• Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications

  2022cites this paper
• Dermatoses inflammatoires et auto-immunes

  2022cites this paper
• Epidemiology of prurigo nodularis in England: a retrospective database analysis

  2022cites this paper
• Chronic Nodular Prurigo: A Retrospective Study of 74 Cases (cid:2)

  2022influential citation
• Anais Brasileiros de Dermatologia Effectiveness of dupilumab for chronic prurigo in elderly patients with atopic dermatitis (cid:2)

  2022cites this paper
• Chronic Nodular Prurigo: An Update on the Pathogenesis and Treatment

  2022influential citation
• Colonization with Staphylococcus aureus in healthcare workers: consequences of hand eczema

  2022cites this paper
• Dupilumab for Chronic Prurigo in Different Backgrounds: A Case Series

  2022cites this paper
• Prurigo Nodularis: A Review of IL-31RA Blockade and Other Potential Treatments

  2022cites this paper
• A Case of Prurigo Nodularis in an Unlikely Setting

  2022cites this paper
• Impact of Chronic Kidney Disease Severity on the Risk of Prurigo Nodularis: A Population-Based Cohort Study

  2022cites this paper